LexDanaLexDanabeta
Inventor

Honchung TSUI

Inventor
CN

Overview

4→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides7%
PatentTitleYear
11,629,147Triazolo-pyrimidine compounds and uses thereof202311,571,420Pyrazine compounds and uses thereof202311,504,375ErbB/BTK inhibitors202211,447,492ERBB receptor inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to DIZAL JIANGSU PHARMACEUTICAL CO LTD (4)· patent assignee history
2022–2023Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DIZAL JIANGSU PHARMACEUTICAL CO LTD42022–2023
Locations
LocationPatentsSpan
CN42022–2023